share

2-Bromo-6-Methyl-8β-[(2-Phenyl-1H-Imidazol-1-Yl)Methyl]Ergoline CAS NO 115219-10-8


Unit Price:

CAS No.:115219-10-8

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

2-Bromo-6-Methyl-8β-[(2-Phenyl-1H-Imidazol-1-Yl)Methyl]Ergoline is a complex, high-purity ergoline derivative, a key intermediate in advanced pharmaceutical research and development. This compound is valued for its precise molecular architecture, which is critical for synthesizing novel therapeutic agents targeting central nervous system receptors. It is primarily utilized by research institutions and pharmaceutical companies engaged in the development of new chemical entities, particularly in the fields of neurology and psychiatry.

Application

  • Pharmaceutical Intermediate: A crucial building block for the synthesis of novel ergot alkaloid-based APIs and investigational drugs.
  • Neurological Research: Used in preclinical studies to develop compounds targeting serotonin and dopamine receptor subtypes.
  • Chemical Reference Standard: Serves as a high-purity analytical standard for method development and quality control in pharmaceutical analysis.
  • Medicinal Chemistry: Enables structure-activity relationship (SAR) studies to optimize pharmacological profiles of new drug candidates.
  • Academic Research: Employed in university and institutional labs for studying the biochemistry and pharmacology of ergoline derivatives.
  • Process Development: Used in scaling up synthetic routes for potential new therapeutics under GMP-like conditions.

Basic Information

Item Detail
Product Name 2-Bromo-6-Methyl-8β-[(2-Phenyl-1H-Imidazol-1-Yl)Methyl]Ergoline
CAS No. 115219-10-8
Molecular Formula C25H25BrN4
Molecular Weight 461.40 g/mol
Synonyms 2-Bromo-6-methyl-8β-[(2-phenyl-1H-imidazol-1-yl)methyl]ergoline; 8β-[(2-Phenyl-1H-imidazol-1-yl)methyl]-2-bromo-6-methylergoline; 2-Bromo-6-methyl-8β-[(2-phenylimidazol-1-yl)methyl]ergoline; 115219-10-8; Bromo-methyl-phenylimidazolylmethylergoline; Ergoline, 2-bromo-6-methyl-8β-[(2-phenyl-1H-imidazol-1-yl)methyl]-; LS-176106
EINECS Contact for details

Quality Control

Every batch of 2-Bromo-6-Methyl-8β-[(2-Phenyl-1H-Imidazol-1-Yl)Methyl]Ergoline is manufactured and tested under strict quality management systems. Our products undergo rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency meet the exacting standards required for pharmaceutical research. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item Specification
Appearance White to off-white powder
Identification (HPLC) Conforms
Identification (IR) Conforms
Purity (HPLC) ≥ 98.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 20 ppm
Single Unknown Impurity (HPLC) ≤ 0.5%
Total Impurities (HPLC) ≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.